Black Rock Inc. Senti Biosciences, Inc. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

A detailed history of Black Rock Inc. transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 40,052 shares of SNTI stock, worth $86,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,052
Previous 40,052 -0.0%
Holding current value
$86,111
Previous $15,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$1.25 - $65.2 $46,780 - $2.44 Million
37,424 Added 1424.05%
40,052 $56,000
Q3 2022

Nov 14, 2022
BUY
$1.33 - $21.7 $3,495 - $57,027
2,628 New
2,628 $6,000

Others Institutions Holding SNTI

# of Institutions
3
Shares Held
342K
Call Options Held
0
Put Options Held
0
View Full List

About Senti Biosciences, Inc.

SNTI Quotes by TradingView
  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $94.1M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email